eCOA Data and Regulatory Scrutiny: What You Should Know

eCOA Data and Regulatory Scrutiny: What You Should Know
June 1, 2018 YPrime

Acceptance of data from clinical trials for decision-making purposes depends on regulatory agencies’ ability to verify the quality and integrity of the data. As new technology platforms emerge, the responsibility falls to technology providers and sponsors to document their data collection strategy while remaining compliant with regulations.

In this webinar, Steve Begley and Colin Cleary talk about what you should know about eCOA data and regulatory scrutiny. They discuss the areas of eSource regulatory compliance that pose the greatest challenges for an organization, including record keeping of eSource documentation, user roles/access and permission, data review and audit trail management. They also discuss the characteristics of a collaborative sponsor/provider partnership that help ease the burden of compliance while improving inspection readiness.

Watch the webinar to learn more about eCOA data and regulatory scrutiny.

WEBINAR

eCOA Data and Regulatory Scrutiny: What You Should Know

Steve Begley and Colin Cleary

RELATED CONTENT

Getting Better Together Initiative eCOA Lexicon

Getting Better Together Initiative eCOA Lexicon

How to Get the Most Out of Your eCOA Data

How to Get the Most Out of Your eCOA Data

Is BYOD right for your  eCOA Clinical Trial?

Is BYOD right for your eCOA Clinical Trial?

LATEST CONTENT

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

Improving DCT Technologies for Efficient and Personalized Delivery

Improving DCT Technologies for Efficient and Personalized Delivery

The Importance of IRT in the Decentralized Clinical Trial Landscape

The Importance of IRT in the Decentralized Clinical Trial Landscape